<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01158365</url>
  </required_header>
  <id_info>
    <org_study_id>LACAC_L_05401</org_study_id>
    <secondary_id>U1111-1115-3484</secondary_id>
    <nct_id>NCT01158365</nct_id>
  </id_info>
  <brief_title>Dermacyd in Odor Reducing.</brief_title>
  <official_title>Single Center, Open, Cross-over, Phase III Study for Comparative Evaluation of Safety Use and Efficacy in the Odor Reduce and Vaginal Moisturize Increase for Intimates Use Products Dermacyd Femina Delicata, Dermacyd Femina Breeze, Dermacyd Teen Sweet Flower, Dermacyd Teen Fresh Mix and Dermacyd Femina Comparing to the Control Product Glycerine Vegetal Soap Granado Traditional.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <brief_summary>
    <textblock>
      Primary Objective:

      - To prove the efficacy superiority in reducing the genital odor and increase hydration in
      mucosa genital comparing the use of Dermacyd (different fragrances) and Glycerine Vegetal
      Soap Granado Traditional

      Secondary Objective:

      - To evaluate the safety in normal conditions of use, verifying clinical signs and lab exams.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of genital odor and increase hydration in genital mucosa</measure>
    <time_frame>From the treatment start to the end of the study (day 67)</time_frame>
    <description>Patient's questionnaire will be completed at V1, V2 and V4. Reduction of vaginal odor, increase in the moisture area, and perception about some items like foam, facility of rinsing, final touch of the mucosa, final fragrance, and cleaning sensation will be rated on a 5-point scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the integrity of the mucosa</measure>
    <time_frame>From the treatment start to the end of the study (day 67)</time_frame>
    <description>Onset of erythema, edema, scaling, blisters or other clinical sign will be evaluated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">230</enrollment>
  <condition>Hygiene</condition>
  <arm_group>
    <arm_group_label>Dermacyd (different fragrances)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 1 until 30: Investigational Product (Dermacyd) Day 31 until 37: wash-out Day 38 until 67: Glycerine Vegetal Soap Granado Traditional</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glycerine Vegetal Soap Granado Traditional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Day 1 until 30: Glycerine Vegetal Soap Granado Traditional Day 31 until 37: wash-out Day 38 until 67: Investigational Product (Dermacyd)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LACTIC ACID (Dermacid)</intervention_name>
    <description>Route of administration: local</description>
    <arm_group_label>Dermacyd (different fragrances)</arm_group_label>
    <arm_group_label>Glycerine Vegetal Soap Granado Traditional</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycerine Vegetal Soap Granado Traditional</intervention_name>
    <description>Route of administration: local</description>
    <arm_group_label>Glycerine Vegetal Soap Granado Traditional</arm_group_label>
    <arm_group_label>Dermacyd (different fragrances)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Perfect mucosa in the product analysis region

          -  Volunteers with active sexual life: normal Papanicolau test performed less than one
             year is mandatory

          -  Bacterioscopy describing the vaginal flora

          -  Negative Trichomonas vaginalis test

          -  Negative Whiff test

          -  Willingness in using preservative in the sexual intercourse during the study period

          -  Use the same category cosmetics products

          -  Willingness in following the study procedures and to be present in the clinic at the
             days and scheduled time for medical evaluations and for application of occlusion

        Exclusion criteria:

          -  Use of antiinflammatory / immunosuppression / antihistaminic drugs

          -  Atopic or allergy history to cosmetic products

          -  Active cutaneous disease (local and/or disseminated) in the evaluated area

          -  Disease which can cause immunosuppression, such as diabetes, HIV, etc.

          -  Endocrine pathology such as thyroid disease, ovarian or adrenal gland disturbs

          -  Intense solar exposure (to get a tan) during the 15 days before the evaluation

          -  Gynecologic treatment until four weeks before the evaluation

          -  Any vaginal infection detected during the inclusion

          -  Other conditions considered by the investigator as reasonable for exclude the patient
             in the study.

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Sciences &amp; Operations</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Investigational Site Number 076-001</name>
      <address>
        <city>Osasco</city>
        <zip>06023-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2010</study_first_submitted>
  <study_first_submitted_qc>July 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2010</study_first_posted>
  <last_update_submitted>January 3, 2011</last_update_submitted>
  <last_update_submitted_qc>January 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Trial Transparency Team</name_title>
    <organization>sanofi-aventis</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

